📰 Scott Struthers News
Page 3 - Scott Struthers News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scott Struthers. Real-time updates on events, politics, business and more.
September 17, 2023
Sanders Morris Harris LLC acquired a new position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 18,600 shares of the company’s stock, valued at approximately $336,000. A number of other institutional investors and […]
September 17, 2023
Sanders Morris Harris LLC acquired a new stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) in the second quarter, according to its most recent filing with the SEC. The fund acquired 18,600 shares of the company’s stock, valued at approximately $336,000. Other hedge funds have also bought and sold shares of the company. Tower […]
September 14, 2023
HC Wainwright reaffirmed their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research note released on Monday, Benzinga reports. HC Wainwright currently has a $33.00 price objective on the stock. A number of other equities research analysts have also weighed in on the stock. Cantor Fitzgerald restated an overweight rating […]
September 14, 2023
Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price objective boosted by Evercore ISI from $41.00 to $48.00 in a research note published on Monday morning, MarketBeat Ratings reports. They currently have an outperform rating on the stock. CRNX has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an overweight […]
September 14, 2023
HC Wainwright reiterated their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently has a $33.00 price target on the stock. Other equities analysts have also recently issued research reports about the stock. JMP Securities cut their price objective on […]
September 14, 2023
Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target upped by Oppenheimer from $40.00 to $46.00 in a report released on Monday morning, Marketbeat reports. The firm currently has an outperform rating on the stock. Other research analysts also recently issued reports about the company. HC Wainwright reissued a buy rating and issued a […]
September 12, 2023
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report)’s share price gapped up before the market opened on Tuesday after Evercore ISI raised their price target on the stock from $41.00 to $48.00. The stock had previously closed at $26.08, but opened at $27.00. Evercore ISI currently has an outperform rating on the stock. Crinetics Pharmaceuticals […]
September 12, 2023
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw some unusual options trading activity on Tuesday. Stock traders bought 2,787 put options on the company. This represents an increase of 269% compared to the typical volume of 756 put options. Insider Activity In other news, CFO Marc Wilson sold 30,922 shares of the firm’s stock […]
September 12, 2023
An oral treatment, developed by the U.S. company Crinetics Pharmaceuticals, Inc., has shown promise as an alternative to injected therapies for tackling the rare disease acromegaly in a phase 3 trial.
September 11, 2023
Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) had its price target lifted by analysts at Robert W. Baird from $43.00 to $45.00 in a note issued to investors on Monday, FlyOnTheWall reports. Robert W. Baird’s target price points to a potential upside of 181.78% from the stock’s current price. A number of other analysts also […]